Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(VIP-neurotensin) hybrid antagonist MeSH Supplementary Concept Data 2025


MeSH Supplementary
(VIP-neurotensin) hybrid antagonist
Unique ID
C069189
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C069189
Entry Term(s)
(Lys(1)-Pro(2,5)-Arg(3,4)-Tyr(6))VIP(7-28)
Lys-Pro-Arg-Arg-Pro-Tyr-VIP(7-28)
VIP Hybrid
VIP-NE hybrid antag
VIPhyb
lysyl-prolyl-arginyl-arginyl-prolyl-tyrosyl-VIP(7-28)
neurotensin(6-11)VIP(7-28)
Registry Numbers
125093-93-8
Previous Indexing
*PEPTIDES (91-95)
*RECOMBINANT FUSION PROTEINS (95-96)
Heading Mapped to
*Neurotensin
Recombinant Fusion Proteins
*Vasoactive Intestinal Peptide
Frequency
17
Note
contains fractions of VIP peptide & neurotensin; 28 amino acid sequence given in first source; consists of an N-terminal sequence from neurotensin and the 22 C-terminal amino acids of vasoactive intestinal peptide (VIP); inhibits VIP receptor
Source
J Pharmacol Exp Ther 1991;257(3):959
Date of Entry
1991/07/10
Revision Date
2007/09/07
(VIP-neurotensin) hybrid antagonist Preferred
Lys-Pro-Arg-Arg-Pro-Tyr-VIP(7-28) Narrower
VIP-NE hybrid antag Narrower
VIPhyb Narrower
lysyl-prolyl-arginyl-arginyl-prolyl-tyrosyl-VIP(7-28) Narrower
neurotensin(6-11)VIP(7-28) Narrower
page delivered in 0.006s